Abstract
As a new high-potency progesterone and the first drug for endometriosis, dienogest has been used in overseas markets for 11 years, accumulating relevant experience in efficacy and safety. This article reviewed the application of dienogest in different types of endometriosis, and the results of clinical trials in Asian patients. It would help the clinicians fully understand the application value of dienogest in the treatment of endometriosis. Key words: Dienogest; Endometriosis; Treatment
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call